Gabelli Funds’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Gabelli Funds’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-575,000	Closed	-$2.3M	–	1143
2019 Q4	$2.3M	Buy	+575,000	New	+$2.7M	0.01%	693
2017 Q1	–	Sell	-49,000	Closed	-$617K	–	1172
2016 Q4	$617K	Sell	49,000 -32,000	-40%	-$596K	﹤0.01%	983
2016 Q3	$2.27M	Hold	81,000	–	–	0.01%	754
2016 Q2	$2.83M	Buy	81,000 +52,000	+179%	+$1.63M	0.02%	709
2016 Q1	$795K	Buy	+29,000	New	+$854K	﹤0.01%	937

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Gabelli Funds's DPLO Position: Q1 2020 in Review

Gabelli Funds sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 575,000 shares — an estimated $2.3M sold.

Gabelli Funds first reported a position in DPLO in Q1 2016 and held it in 5 quarters. The position peaked at $2.83M in Q2 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Gabelli Funds reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Gabelli Funds sold 575,000 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2.3M.
Gabelli Funds first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 5 quarters.
Gabelli Funds's DIPLOMAT PHARMACY, INC. position peaked at $2.83M in Q2 2016.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Gabelli Funds's 13F filing for Q1 2020, filed 14 May 2020.